Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma

被引:0
|
作者
Friedrich, RE
Bartel-Friedrich, S
Lobeck, H
Niedobitek, G
Arps, H
机构
[1] Univ Hamburg, Eppendorf Univ Hosp, Nordwestdeutsch Kieferklin, Klin MKG Chirurg,Dept Oral & Maxillofacial Surg, D-20246 Hamburg, Germany
[2] Univ Halle Wittenberg, Halle, Germany
[3] Free Univ Berlin, Charite, Dept Pathol, D-1000 Berlin, Germany
[4] Free Univ Berlin, Benjamin Franklin Hosp, Dept Pathol, D-1000 Berlin, Germany
[5] Gen Hosp, Dept Pathol, Fulda, Germany
关键词
undifferentiated carcinoma; nasopharyngeal carcinoma; intermediate filaments; Epstein-Barr virus; cytokeratins;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate the expression of intermediate filaments (cytokeratin, vimentin), epithelial membrane antigen (EMA) and the presence of Epstein-Barr virus (EBV) DNA in undifferentiated nasophalyngeal carcinoma (NPC). A high incidence of nuclear signals in NPC was Sound in primaries and regional lymph node metastases (70%), using S-35-labelled probes of EBV plasmids for in-situ hybridization. Keratinizing squamous cell carcinomas were EBV-negative. All carcinomas were immune-reactive for cytokeratin (KL-1). 45% of the carcinomas were positive for vimentin. The expression of epithelial membrane antigen was restricted to epithelial cells and reduced in NPC as compared to the distribution pattern of cytokeratin. Both EBV DNA and vimentin in NPC were present in 9 cases. However, in 5 cases NPG were harboring EBV but were not immunoreactive for anti-vimentin antibodies. In no case was a vimentin-positive NPC also EBV-negative. The identification of cytokeratin subtypes revealed no specific cytokeratin pattern in NPC. The expression of vimentin in NPC is not specific for EBV, but seems to reflect the loss of intel-epithelial contact in anaplastic carcinomas.
引用
收藏
页码:4909 / 4916
页数:8
相关论文
共 50 条
  • [1] Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma
    Reinhard E. Friedrich
    Sylva Bartel-Friedrich
    Hartmut Lobeck
    Gerald Niedobitek
    Hartmut Arps
    Medical Microbiology and Immunology, 2003, 192 : 141 - 144
  • [2] Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma
    Friedrich, RE
    Bartel-Friedrich, S
    Lobeck, H
    Niedobitek, G
    Arps, H
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2003, 192 (03) : 141 - 144
  • [3] Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
    Hau, Pok Man
    Lung, Hong Lok
    Wu, Man
    Tsang, Chi Man
    Wong, Ka-Leung
    Mak, Nai Ki
    Lo, Kwok Wai
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Epstein-Barr virus infection and nasopharyngeal carcinoma
    Tsao, Sai Wah
    Tsang, Chi Man
    Lo, Kwok Wai
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2017, 372 (1732)
  • [5] The role of Epstein-Barr virus in nasopharyngeal carcinoma
    Su, Zhi Yi
    Siak, Pui Yan
    Leong, Chee-Onn
    Cheah, Shiau-Chuen
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [6] Epstein-Barr virus and nasopharyngeal carcinoma
    Lawrence SYoung
    Christopher WDawson
    ChineseJournalofCancer, 2014, 33 (12) : 581 - 590
  • [7] Epstein-Barr virus and nasopharyngeal carcinoma
    Young, Lawrence S.
    Dawson, Christopher W.
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 581 - 590
  • [8] Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma
    Paramita, Dewi K.
    Fachiroh, Jajah
    Artama, Wayan T.
    van Benthem, Eric
    Haryana, Sofia M.
    Middeldorp, Jaap M.
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1710 - 1721
  • [10] Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
    Chan, K. C. Allen
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 598 - 603